Status:

RECRUITING

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Lead Sponsor:

Hunter Holmes Mcguire Veteran Affairs Medical Center

Collaborating Sponsors:

Grifols Biologicals, LLC

Conditions:

Cirrhosis

Hepatic Encephalopathy

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Hypothesis: Improvement in cognitive dysfunction with IV albumin in patients with cirrhosis with prior HE and MHE lasts for several weeks after albumin infusion has ended, and is due to persistent imp...

Detailed Description

In outpatients with cirrhosis with prior HE who have cognitive impairment despite adequate therapy, how long the impact of albumin lasts and through which potential mechanism(s) needs to be determined...

Eligibility Criteria

Inclusion

  • Age \>18 years
  • Cirrhosis diagnosed using either (a) liver biopsy, (b) transient wave elastography (\>20 KPa) (c) radiological evidence consistent with cirrhosis, (d) in a patient with chronic liver disease endoscopic or radiological evidence of varices (e), in a patient with chronic liver disease, platelet count \<150,000/mm3 and AST/ALT ratio \>1.
  • Cognitive impairment defined by MHE on psychometric hepatic encephalopathy score (PHES), critical flicker frequency (CFF), or EncephalApp Stroop
  • Prior HE controlled by lactulose or rifaximin for at least one month
  • Serum albumin \<4gm/dl

Exclusion

  • Unclear diagnosis of cirrhosis
  • No prior overt HE
  • No cognitive impairment on the tests noted
  • Requiring regular albumin infusions within 3 months or anticipated during the study visit
  • Infection within a month
  • Allergies to albumin
  • Unlikely to be adherent to the study
  • Unable or unwilling to consent
  • West Haven Criteria\>2
  • Alcohol abuse within 1 month
  • Serum albumin \>4gm/dl
  • Congestive heart failure

Key Trial Info

Start Date :

November 2 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06052176

Start Date

November 2 2023

End Date

October 1 2026

Last Update

February 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, United States, 23249